- Lobbying
- abbvie
Lobbying Arrangements Results for 'Abbvie'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Legislative issues related to endometriosis and uterine fibroids education |
AbbVie Inc.
|
Mager & Associates LLC | |||
Details Military Construction and Veterans Affairs and Related Agencies Appropriations Act |
AbbVie Inc.
|
SRB Strategic, LLC | |||
Details Monitoring issues related to corporate tax reform |
AbbVie
|
Lincoln Policy Group | |||
Details Monitoring and advocacy regarding U.S. tax reform and changes to U.S. Tax Code. |
AbbVie
|
NIXON PEABODY LLP | |||
Details Issues related to the 340B drug discount program. |
AbbVie Inc.
|
MARSHALL & POPP, LLC | |||
Details Monitored issues and legislation related to the 340(b) program. H.R.5801: HELP Copays Act. Medicare Implementation of the Inflation Reduction Act. |
AbbVie Inc.
|
W Strategies, LLC | |||
Details issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid. Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act. Issu... |
Peck Madigan Jones (On behalf of AbbVie Inc.)
|
Tiber Creek Health Strategies, Inc. | |||
Details Issues related to coverage and reimbursement of pharmaceutical products. Issues related to screening and treatment of hepatitis C, oncology and rheumatoid arthritis. Coverage of pharmaceuticals, co... |
AbbVie Inc.
|
Thorn Run Partners | |||
Details International tax issues and pharmaceutical pricing and access issues, and patent issues. |
AbbVie Inc.
|
Cornerstone Government Affairs, Inc. | |||
Details Issues related to the taxation of the biopharmaceutical industry including international taxation |
The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma
lobbying firm |
DOMER CONSULTING, LLC | |||
Details S.142, Preserve Access to Affordable Generics and Biosimilars Act Patent litigation reform issues and issues related to post-grant proceedings at the USPTO Value of intellectual property H.R. 830... |
AbbVie, Inc.
|
in-house lobbying | |||
Details Legislative services related to corporate and international tax matters. |
Abbvie
|
CAPITOL TAX PARTNERS, LLP | |||
Details Patent settlements. Issues related to coverage and reimbursement of pharmaceuticals. Issues related to Medicare, Medicaid and Affordable Care Act implementation. Issues related to the launch of Abb... |
AbbVie Inc.
|
Peck Madigan Jones | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
AbbVie, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Discussions related to health care reform, access to health care, drug pricing, PDUFA Reauthorization, and international access to medicines; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169)... |
AbbVie Inc.
|
Ogilvy Government Relations | |||
Details issues related to corporate and international tax reform including, IRC sections 904(d), 951A, 250, 59A, 163(j), 954(c)(6), 172, 174 and 965. Issues related to Puerto Rico incentives and excise ta... |
WTPPG on Behalf of Alliance for Biopharmaceutical Competitiveness & Innovation
|
JAHANIAN STRATEGIES LLC | |||
Details Patient Access to drug treatment therapies; and drug cost and drug pricing reform. Oversight of the pharmaceutical industry and drug pricing. H.R.830 - HELP Copays Act S. 1375 - HELP Copays Act ... |
AbbVie, Inc.
|
FEDERAL STREET STRATEGIES, LLC | |||
Details Pharmaceutical distribution and supply chain security. |
Pharmaceutical Distribution Security Alliance (PDSA)
|
Leavitt Partners, LLC | |||
Details H.R. 5378: Lower Costs, More Transparency Act 340B, transparency, prescription drug pricing and access, beneficiary access, IRA implementation Part B, Part D, drug pricing and access, negotiation |
AbbVie Inc.
|
TARPLIN, DOWNS & YOUNG, LLC | |||
Details Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 951... |
Alliance for Biopharmaceutical Competitiveness and Innovation
|
The Washington Tax & Public Policy Group (formerly The Washington Tax Group) | |||
Details Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to Patent reform Implementation of Inflation Reduction Act of 2022 HELP Copays Act |
ABBVIE
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP |